Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease

NCT00329160 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesteremia

Interventions

DRUG: Rosuvastatin
DRUG: HMG CoA inhibitor

Sponsor

AstraZeneca

Collaborators

[object Object]